The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic factors that affect survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223.
 
Esmail Mutahar Al-Ezzi
No Relationships to Disclose
 
Husam Alqaisi
No Relationships to Disclose
 
Sarah Picardo
No Relationships to Disclose
 
Marco Iafolla
No Relationships to Disclose
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Janssen (Inst)
 
Adrian G. Sacher
Honoraria - AstraZeneca; Genentech/Roche; Merck; Pfizer
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; Gritstone Bio; Pfizer
 
Nazanin Fallah-Rad
Honoraria - Bayer; Ipsen
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Nektar
 
Charles Catton
Honoraria - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Padraig Warde
No Relationships to Disclose
 
Robert James Hamilton
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen
Travel, Accommodations, Expenses - Janssen
 
Neil Eric Fleshner
Honoraria - Abbvie; Amgen; Astellas Medivation; Bayer; Ferring; Janssen Oncology; Sanofi
Consulting or Advisory Role - Hybridyne Health
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Ferring (Inst); Janssen Oncology (Inst); Nucleix (Inst); Progenix (Inst); Spectracure (Inst)
 
Alexandre Zlotta
Consulting or Advisory Role - Ferring; Janssen; Sanofi
 
Aaron Richard Hansen
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Novartis
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst)